绥美凯是哪里生产的？

On January 22, 2018, innovative AIDS treatment drugs officially entered the Chinese market.

Trimax is currently the only three-in-one compound drug containing dolutegravir (DTG), which integrates treatment drugs for different stages of viral infection into the same tablet. Patients only need to take one drug to achieve the effect of the combination. The drug has been approved for marketing in 50 countries and regions, and has been recommended by many authoritative academic institutions and authoritative guidelines in Europe and the United States as the first-line first-line treatment for patients with HIV infection.

One tablet of Suimeikai contains three antiviral drugs. One tablet is a complete treatment plan. One tablet per day can achieve the effect of cocktail therapy without food restrictions.

Suimeike is used for the treatment of HIV-1 infection. It is the only three-in-one compound drug containing dolutegravir. It is taken once a day and takes one tablet. It has the characteristics of high efficiency, good tolerance, high resistance barrier and few drug interactions. So where is Suimeike produced?

Suimeikai manufacturer: ViiV Healthcare, a joint venture company under GlaxoSmithKline (GSK)

It is understood that the price of Suimeikai in China is 2880$/box. The price is the lowest among surrounding countries and regions.

Since Suimeikai is an imported original drug in China, it is very expensive and most patients cannot afford it. Therefore, many patients choose Suimeikai, which is launched in India.

Generic drug manufacturer of Trimax: India

Produced by the Indian company Emcure, there are 30 tablets in a box, and the price is about RMB 1,000. Due to the floating exchange rate, the price cannot be determined. Please consult the medical companion for the specific price. Patients can choose different versions according to their own conditions!

Recommended related hot articles: /newsDetail/71872.html